Suppr超能文献

载脂蛋白 E:结构见解与阿尔茨海默病发病机制的关联。

Apolipoprotein E: Structural Insights and Links to Alzheimer Disease Pathogenesis.

机构信息

Department of Neurology, Washington University in St. Louis, St. Louis, MO, USA; Hope Center for Neurological Disorders, Washington University in St. Louis, St. Louis, MO, USA; Knight Alzheimer's Disease Research Center, Washington University in St. Louis, St. Louis, MO, USA; The Division of Biology and Biomedical Sciences, Washington University in St. Louis, St. Louis, MO, USA; Department of Pathology and Immunology, Washington University in St. Louis, St. Louis, MO, USA.

Department of Neurology, Washington University in St. Louis, St. Louis, MO, USA; Hope Center for Neurological Disorders, Washington University in St. Louis, St. Louis, MO, USA; Knight Alzheimer's Disease Research Center, Washington University in St. Louis, St. Louis, MO, USA; The Division of Biology and Biomedical Sciences, Washington University in St. Louis, St. Louis, MO, USA.

出版信息

Neuron. 2021 Jan 20;109(2):205-221. doi: 10.1016/j.neuron.2020.10.008. Epub 2020 Nov 10.

Abstract

Apolipoprotein E (ApoE) is of great interest due to its role as a cholesterol/lipid transporter in the central nervous system (CNS) and as the most influential genetic risk factor for Alzheimer disease (AD). Work over the last four decades has given us important insights into the structure of ApoE and how this might impact the neuropathology and pathogenesis of AD. In this review, we highlight the history and progress in the structural and molecular understanding of ApoE and discuss how these studies on ApoE have illuminated the physiology of ApoE, receptor binding, and interaction with amyloid-β (Aβ). We also identify future areas of study needed to advance our understanding of how ApoE influences neurodegeneration.

摘要

载脂蛋白 E(ApoE)作为中枢神经系统(CNS)中的胆固醇/脂质转运蛋白,以及阿尔茨海默病(AD)最具影响力的遗传风险因素,备受关注。过去四十年的研究使我们对 ApoE 的结构有了重要的了解,并且深入探讨了这将如何影响 AD 的神经病理学和发病机制。在本综述中,我们重点介绍了 ApoE 的结构和分子理解方面的历史和进展,并讨论了这些关于 ApoE 的研究如何阐明了 ApoE 的生理学、受体结合以及与淀粉样蛋白-β(Aβ)的相互作用。我们还确定了未来需要研究的领域,以增进我们对 ApoE 如何影响神经退行性变的理解。

相似文献

1
Apolipoprotein E: Structural Insights and Links to Alzheimer Disease Pathogenesis.
Neuron. 2021 Jan 20;109(2):205-221. doi: 10.1016/j.neuron.2020.10.008. Epub 2020 Nov 10.
4
Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease.
Cold Spring Harb Perspect Med. 2012 Mar;2(3):a006312. doi: 10.1101/cshperspect.a006312.
6
The E3 ubiquitin ligase Idol controls brain LDL receptor expression, ApoE clearance, and Aβ amyloidosis.
Sci Transl Med. 2015 Nov 18;7(314):314ra184. doi: 10.1126/scitranslmed.aad1904.
7
Low-density lipoprotein receptor represents an apolipoprotein E-independent pathway of Aβ uptake and degradation by astrocytes.
J Biol Chem. 2012 Apr 20;287(17):13959-71. doi: 10.1074/jbc.M111.288746. Epub 2012 Mar 1.
8
Lack of LDL receptor enhances amyloid deposition and decreases glial response in an Alzheimer's disease mouse model.
PLoS One. 2011;6(7):e21880. doi: 10.1371/journal.pone.0021880. Epub 2011 Jul 6.
9
Amyloid-β protein modulates the perivascular clearance of neuronal apolipoprotein E in mouse models of Alzheimer's disease.
J Neural Transm (Vienna). 2011 May;118(5):699-712. doi: 10.1007/s00702-010-0572-7. Epub 2011 Jan 6.
10
Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism.
Ann N Y Acad Sci. 2000;924:81-90. doi: 10.1111/j.1749-6632.2000.tb05564.x.

引用本文的文献

3
A computational framework for identifying chemical compounds to bind Apolipoprotein E4 for Alzheimer's disease intervention.
Front Syst Biol. 2023 Jun 14;3:1188430. doi: 10.3389/fsysb.2023.1188430. eCollection 2023.
5
Lewy body dementia: exploring biomarkers and pathogenic interactions of amyloid β, tau, and α-synuclein.
Mol Neurodegener. 2025 Aug 12;20(1):90. doi: 10.1186/s13024-025-00879-0.
6
The complex web of membrane contact sites in brain aging and neurodegeneration.
Cell Mol Life Sci. 2025 Aug 8;82(1):301. doi: 10.1007/s00018-025-05830-6.
8
Insights into targeted ferroptosis in mechanisms, biology, and role of Alzheimer's disease: an update.
Front Aging Neurosci. 2025 Jul 21;17:1587986. doi: 10.3389/fnagi.2025.1587986. eCollection 2025.
9
Brain Structures Associated with Depression in Older Adults in the National Alzheimer's Coordinating Center Uniform Data Set.
J Geriatr Psychiatry Neurol. 2025 Aug 4:8919887251361101. doi: 10.1177/08919887251361101.

本文引用的文献

1
Crystal structure of a proteolytically cleaved, amino terminal domain of apolipoprotein E3.
Biochem Biophys Res Commun. 2020 Feb 17. doi: 10.1016/j.bbrc.2020.01.117.
2
genotype regulates pathology and disease progression in synucleinopathy.
Sci Transl Med. 2020 Feb 5;12(529). doi: 10.1126/scitranslmed.aay3069.
3
APOE4 exacerbates α-synuclein pathology and related toxicity independent of amyloid.
Sci Transl Med. 2020 Feb 5;12(529). doi: 10.1126/scitranslmed.aay1809.
4
Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report.
Nat Med. 2019 Nov;25(11):1680-1683. doi: 10.1038/s41591-019-0611-3. Epub 2019 Nov 4.
5
Lack of hepatic apoE does not influence early Aβ deposition: observations from a new APOE knock-in model.
Mol Neurodegener. 2019 Oct 17;14(1):37. doi: 10.1186/s13024-019-0337-1.
6
Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model.
J Exp Med. 2019 Nov 4;216(11):2546-2561. doi: 10.1084/jem.20190980. Epub 2019 Oct 10.
7
High-affinity multivalent interactions between apolipoprotein E and the oligomers of amyloid-β.
FEBS J. 2019 Dec;286(23):4737-4753. doi: 10.1111/febs.14988. Epub 2019 Jul 19.
9
The Molecular Basis for Apolipoprotein E4 as the Major Risk Factor for Late-Onset Alzheimer's Disease.
J Mol Biol. 2019 May 31;431(12):2248-2265. doi: 10.1016/j.jmb.2019.04.019. Epub 2019 Apr 30.
10
APOE4-mediated amyloid-β pathology depends on its neuronal receptor LRP1.
J Clin Invest. 2019 Mar 1;129(3):1272-1277. doi: 10.1172/JCI124853. Epub 2019 Feb 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验